According to Minerva Neurosciences 's latest financial reports the company's current earnings (TTM) are -$30.01 M. In 2022 the company made an earning of -$32.11 M an increase over its 2021 earnings that were of -$51.71 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$30.01 M | -6.55% |
2022 | -$32.11 M | -37.91% |
2021 | -$51.71 M | -2764.37% |
2020 | $1.94 M | -102.61% |
2019 | -$74.44 M | 48.37% |
2018 | -$50.18 M | 22.67% |
2017 | -$40.9 M | 31.74% |
2016 | -$31.05 M | 14.64% |
2015 | -$27.09 M | -52.41% |
2014 | -$56.91 M | 1644.37% |
2013 | -$3.27 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Incyte INCY | $0.83 B | -2,880.22% | ๐บ๐ธ USA |
Dynavax Technologies
DVAX | $2.66 M | -108.89% | ๐บ๐ธ USA |
Clovis Oncology CLVS | -$0.22 B | 624.55% | ๐บ๐ธ USA |